Comments on: “Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity”

Olaf van Tellingen, Mark C. de Gooijer, Jann N. Sarkaria, William F. Elmquist

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1404-1405
Number of pages2
JournalNeuro-Oncology
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2020

PubMed: MeSH publication types

  • Journal Article
  • Comment

Cite this